Sergio Cifuentes: My insights on a recent study Keynote A18 from The Lancet, Domenica Lorusso and Ana Oaknin
Sergio Cifuentes, Cancer Research Project Manager at
“My insights on a recent study Keynote A18 from The Lancet, Domenica Lorusso and Ana Oaknin.
Always striving to stay updated and contribute to the latest research in the field.
Today this editorial its more relevant on managing recurrent RCC after adjuvant pembrolizumab. With positive results from KN 564 in adjuvant therapy for RCC, it’s crucial to refine patient care strategies post-adjuvant IO.”
View the article attached to the post.
Source: Sergio Cifuentes/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”